Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo
- PMID: 12959943
- DOI: 10.1182/blood-2003-05-1655
Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo
Similar articles
-
DC-like cell-dependent activation of human natural killer cells by the bisphosphonate zoledronic acid is regulated by γδ T lymphocytes.Blood. 2011 Sep 8;118(10):2743-51. doi: 10.1182/blood-2011-01-328526. Epub 2011 Jun 14. Blood. 2011. PMID: 21673342
-
Peripheral blood monocytes are responsible for gammadelta T cell activation induced by zoledronic acid through accumulation of IPP/DMAPP.Br J Haematol. 2009 Jan;144(2):245-50. doi: 10.1111/j.1365-2141.2008.07435.x. Epub 2008 Nov 7. Br J Haematol. 2009. PMID: 19016713 Free PMC article.
-
Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma.Leukemia. 2005 Apr;19(4):664-70. doi: 10.1038/sj.leu.2403693. Leukemia. 2005. PMID: 15744346
-
Nano-technology based carriers for nitrogen-containing bisphosphonates delivery as sensitisers of γδ T cells for anticancer immunotherapy.Adv Drug Deliv Rev. 2017 May 15;114:143-160. doi: 10.1016/j.addr.2017.07.003. Epub 2017 Jul 8. Adv Drug Deliv Rev. 2017. PMID: 28694026 Review.
-
Bisphosphonate therapy in multiple myeloma: past, present, future.Eur J Haematol. 2002 Nov-Dec;69(5-6):257-64. doi: 10.1034/j.1600-0609.2002.02796.x. Eur J Haematol. 2002. PMID: 12460229 Review.
Cited by
-
Prevention of Bone Metastases in Breast Cancer Patients. Therapeutic Perspectives.J Clin Med. 2014 May 9;3(2):521-36. doi: 10.3390/jcm3020521. J Clin Med. 2014. PMID: 26237389 Free PMC article. Review.
-
The invisible arm of immunity in common cancer chemoprevention agents.Cancer Prev Res (Phila). 2013 Aug;6(8):764-73. doi: 10.1158/1940-6207.CAPR-13-0036. Cancer Prev Res (Phila). 2013. PMID: 23918793 Free PMC article. Review.
-
Polysaccharides derived from Yamoa (Funtumia elastica) prime gammadelta T cells in vitro and enhance innate immune responses in vivo.Int Immunopharmacol. 2009 Oct;9(11):1313-22. doi: 10.1016/j.intimp.2009.07.015. Epub 2009 Aug 9. Int Immunopharmacol. 2009. PMID: 19671448 Free PMC article.
-
Development and Selection of the Human Vγ9Vδ2+ T-Cell Repertoire.Front Immunol. 2018 Jul 2;9:1501. doi: 10.3389/fimmu.2018.01501. eCollection 2018. Front Immunol. 2018. PMID: 30013562 Free PMC article. Review.
-
Aminobisphosphonates prevent the inhibitory effects exerted by lymph node stromal cells on anti-tumor Vδ 2 T lymphocytes in non-Hodgkin lymphomas.Haematologica. 2014 Jan;99(1):131-9. doi: 10.3324/haematol.2013.097311. Epub 2013 Oct 25. Haematologica. 2014. PMID: 24162786 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical